Two blood molecules could predict future decline of mental abilities and progression to Alzheimer’s disease in people with mild cognitive impairments, a new study suggests.
University of Oxford
Brazilian president Jair Bolsonaro has said he won’t take any working Covid-19 vaccine himself and called the use of masks “the last taboo to fall”.
Thailand has signed a deal to procure 26 million doses of the trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca with Oxford University. It is expected to be delivered in mid-2021.
An inhaled steroid will be investigated as a possible treatment for coronavirus as part of a national trial.
Higher than normal blood pressure in midlife may be linked to more extensive brain damage in the elderly, new research suggests.
Three potential coronavirus vaccines to which the UK has secured access have reported they may be about 90% effective
Using a half dose of the Oxford Covid vaccine before delivering a full dose could “prime” the body to create a better immune response, scientists have said.
Social restrictions could start to be eased by spring, one scientist has said, after the University of Oxford and AstraZeneca published their early trial data for their Covid vaccine.
The AstraZeneca/Oxford University Covid-19 vaccine has reported interim results from a phase 3 trial showing the jab can prevent the majority of people from developing the disease.
Experts have hailed the initial results from the University of Oxford’s Covid-19 vaccine as “encouraging”, as data from the latest trial suggests it produces a strong immune response in older people.
Hopes have been raised that the UK could produce a successful coronavirus vaccine after data from the University of Oxford showed its jab provokes a strong immune response in older people.
Results showing the effectiveness of the University of Oxford’s coronavirus vaccine are expected to be released in the coming weeks.
The University of Oxford is expected to release data on the effectiveness of its coronavirus vaccine in the coming weeks, with the latest trial results suggesting it produces a strong immune response in older adults.
Experts have welcomed the news that the promising Covid vaccine candidate developed by Pfizer is effective among the elderly.
US company Moderna has announced its coronavirus vaccine may be 94.5% effective against Covid-19.
Time spent playing video games can be good for your wellbeing, according to a new study which looked at data provided by games firms.
The European Space Agency (ESA) has given the green light to the world’s first space telescope – dubbed the planet hunter – to study the atmospheres of planets outside our solar system.
The UK is making plans to roll out a coronavirus vaccine as soon as one is approved.
Severe coronavirus infection appears to be rare in newborn babies, a new study suggests.
Having coronavirus may be linked to an increase in a person’s risk of psychiatric disorders, and having a psychiatric disorder is linked to an increased chance of contracting Covid-19, a new study suggests.
Governments should consider incentivising people to get a Covid-19 vaccine in order to achieve the required level of herd immunity, an expert has said.
Coronavirus antibodies fall by half in less than 90 days and fall faster in younger adults, new research suggests.
Drugs giant AstraZeneca has confirmed it expects to present the data from its Covid-19 vaccine, being developed with the University of Oxford, by the end of the year.
Researchers looking at coronavirus treatments for the over 50s are considering including younger people in the trials as issues surrounding long Covid become clearer.
Parks and libraries should be closed as a “last resort” during any potential future lockdowns, researchers have said.
A “significant” proportion of Covid-19 patients admitted to hospital will still suffer adverse symptoms three months after being sent home, a new study has suggested.
Scientists have developed a new rapid test for coronavirus that detects and identifies viruses in less than five minutes.
A new study will look at the effectiveness of a drug used to treat inflammatory conditions as a treatment for patients with coronavirus in the community, especially care homes.
Human trials of the coronavirus vaccine being developed by the University of Oxford and AstraZeneca have been put on hold owing to a reported side effect in a patient in the UK.
Global communities most at risk from the impact of coronavirus due to long-term conflict, food and water shortages, and crowded living conditions will get a funding boost from the UK.